Revenue and earnings grew strongly in H1 2026, led by Specialty Chemicals, with EBITDA up 14% and margins expanding. Major capacity expansions in Germany and the U.S. are on track, and full-year guidance is confirmed, despite ongoing ramp-up costs and weak agriculture demand.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.